CDS

LEADING EDGE MATERIALS ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD THURSDAY, APRIL 25, 2024

Retrieved on: 
Wednesday, March 27, 2024
Remuneration, Computershare, 14th Floor Records, Notice, Corporation, Euroclear, CDS, FRA, Bank statement

The record date for the Meeting is March 19, 2024.

Key Points: 
  • The record date for the Meeting is March 19, 2024.
  • The Notice of Meeting, the accompanying Management Proxy Circular and related meeting materials are available under the Company’s profile on SEDAR at www.sedar.com and on the Company’s website at https://leadingedgematerials.com/ .
  • The information in this section is of significance to Shareholders who hold their securities (“Euroclear Registered Securities“) through Euroclear Sweden AB, which securities trade on the Nasdaq First North.
  • Shareholders who hold Euroclear Registered Securities are not registered holders of voting securities for the purposes of voting at the Meeting.

Wolters Kluwer supports Brazil with access to trusted medical content on Dengue disease

Retrieved on: 
Friday, March 15, 2024
Software, Networks, Internet, Data Management, Public Safety, Technology, Infectious Diseases, Hospitals, Health Technology, Practice Management, Health, Public Policy, Government, Diagnosis, Risk, CDS, Growth, UpToDate, Physician, Disease, Wolters Kluwer, Vaccine

With the significant growth of Dengue cases in Brazil, Wolters Kluwer Health is providing free, online access to evidence-based information about the disease from its clinical decision support (CDS) resource, UpToDate .

Key Points: 
  • With the significant growth of Dengue cases in Brazil, Wolters Kluwer Health is providing free, online access to evidence-based information about the disease from its clinical decision support (CDS) resource, UpToDate .
  • Access is available to doctors, even if they are not UpToDate subscribers, as well as to the general community by visiting this link .
  • Nine states and 201 Brazilian municipalities have declared a health emergency due to the high volume of cases of the disease.
  • To access information and recommendations about the virus, simply access the link .

Wolters Kluwer Redefines Clinical Decision Support for Tomorrow’s Healthcare

Retrieved on: 
Monday, March 11, 2024
Software, General Health, Accounting, Professional Services, Pharmaceutical, Technology, Hospitals, Artificial Intelligence, Finance, Other Technology, Environmental, Social and Governance (ESG), Health, Informatics, SSM Health, Organization, Conference, UpToDate, Efficacy, Frost, Caregiver, Wolters Kluwer, Education, Patient, CMIO, CDS, Black Book, Integration, AI, LLM, CME, Workflow, Pathway, Investment, SSO, Exhibition, Clinical decision support system, Nursing

Wolters Kluwer Health today unveiled the next generation of clinical decision support (CDS) solutions, bringing together point-of-care decision support, workflow optimization, and patient-centered care resources into unified, interoperable user experiences.

Key Points: 
  • Wolters Kluwer Health today unveiled the next generation of clinical decision support (CDS) solutions, bringing together point-of-care decision support, workflow optimization, and patient-centered care resources into unified, interoperable user experiences.
  • Wolters Kluwer Health has launched two tailored product experiences, serving different customers.
  • Products from both suites will be demonstrated at the Wolters Kluwer booth #2927, at the HIMSS24 Global Conference and Exhibition .
  • Watch this video to learn more about how Wolters Kluwer is redefining Clinical Decision Support for tomorrow’s healthcare.

Wolters Kluwer strengthens Clinical GenAI market leadership with AI Labs powered by UpToDate

Retrieved on: 
Monday, March 11, 2024
General Health, Health, Other Technology, Technology, Artificial Intelligence, UMass Memorial Health, Conference, UpToDate, Efficacy, Frost, Wolters Kluwer, CDS, Hospital, AI, MD, Senior, Emergency department, LLM, Safety, Exhibition, Gen, Medical device

Wolters Kluwer Health today announced several key milestones for AI Labs, the Clinical Generative AI (GenAI) beta launched in 2023 and powered by UpToDate®, the globally trusted clinical decision support (CDS) solution.

Key Points: 
  • Wolters Kluwer Health today announced several key milestones for AI Labs, the Clinical Generative AI (GenAI) beta launched in 2023 and powered by UpToDate®, the globally trusted clinical decision support (CDS) solution.
  • AI Labs now has access to the complete set of UpToDate’s evidence-based clinical content and graded recommendations across more than 25 medical specialties.
  • “Wolters Kluwer is focused on setting the standard for Clinical GenAI a transformative solution that creates an interactive experience for clinicians and care teams.
  • AI Labs will be demonstrated at the Wolters Kluwer booth, #2927, at the HIMSS24 Global Conference and Exhibition .

ICD 2024 Client Survey Shows Companies Grappling with Counterparty Concentration Risk

Retrieved on: 
Wednesday, March 20, 2024
Intelligence, Risk, CDS, Credit Suisse, ICD, NYCB, Silicon, Investment, Treasury, New York Community Bank, Community Bank, Bank

According to the 2024 ICD Client Survey , which closed in February, 80% of respondents say they are highly or moderately concerned with bank failures, while 74% say they are concerned with counterparty concentration risk .

Key Points: 
  • According to the 2024 ICD Client Survey , which closed in February, 80% of respondents say they are highly or moderately concerned with bank failures, while 74% say they are concerned with counterparty concentration risk .
  • Our cloud solution for portfolio analytics leverages AI to create a single data set of our clients' entire investment portfolio so they can effectively manage counterparty risk," Hazard says.
  • "ICD Portfolio Analytics reporting would have given practitioners actionable intelligence to mitigate counterparty exposure leading up to the March 2023 banking failures," Hazard says.
  • For further insights into corporate treasury's views on the short-term market and technology, read the 2024 ICD Client Survey report at icdportal.com/resources .

Labroots Announces its 8th Annual Laboratory Automation Virtual Event, Scheduled on March 20, 2024

Retrieved on: 
Thursday, March 14, 2024
Automaton, Automation, Receptor, Almost, Q&A, Cell, Protein, Laboratory automation, MIT, LIMS, Sartorius, CDS, Research, Science News, WEI, Media lab, Science, Doctor of Philosophy, Networking hardware, Laboratory, Cytokine, CRISPR, Immortalised cell line, Labroots, Molecular biology, Medicine, UCLA, Antigen

YORBA LINDA, Calif., March 14, 2024 /PRNewswire-PRWeb/ -- Labroots, the leading scientific social networking website, offering premier, interactive virtual events and webinars, is delighted to host its 8th annual Laboratory Automation online event on March 20, 2024. This free event brings together thousands of research scholars, scientists, and laboratory personnel from leading academic and industry institutions under a virtual roof to explore scientific disciplines with sessions spanning microfluidic and microscale technologies for automation, automation and emerging methods, lab automation with cutting-edge tools, LIMS and other automation software, and analytics for high-throughput and high content assays.

Key Points: 
  • YORBA LINDA, Calif., March 14, 2024 /PRNewswire-PRWeb/ -- Labroots , the leading scientific social networking website, offering premier, interactive virtual events and webinars, is delighted to host its 8th annual Laboratory Automation online event on March 20, 2024.
  • The insightful agenda encompasses leading-edge advancements aimed at automating and accelerating research, and amplifying efficiency in the lab.
  • A lively Q&A session, following the presentation sponsored by Automata titled, "How to Prepare for Lab Automation."
  • Participants can use the official hashtag #LRlabauto to follow the conversation and connect with other members in the Laboratory Automation community!

Sprott Inc. Declares Fourth Quarter 2023 Dividend

Retrieved on: 
Tuesday, February 20, 2024
CDS, Depository Trust Company, Cede and Company, SII

TORONTO, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Sprott Inc. (“Sprott” or the “Company”) (NYSE/TSX: SII) announced today that its Board of Directors has declared a fourth quarter 2023 dividend of US$0.25 per common share, payable on March 19, 2024 to shareholders of record at the close of business on March 4, 2024.

Key Points: 
  • TORONTO, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Sprott Inc. (“Sprott” or the “Company”) (NYSE/TSX: SII) announced today that its Board of Directors has declared a fourth quarter 2023 dividend of US$0.25 per common share, payable on March 19, 2024 to shareholders of record at the close of business on March 4, 2024.
  • However, beneficial holders whose intermediary is a participant in CDS, may elect to change the currency of their dividend payments to U.S. dollars and can contact their broker for more details.
  • Registered shareholders, other than CDS, who are residents of Canada and wish to receive their dividend in U.S. dollars should make arrangements to deposit their common shares with CDS, and make a currency election, prior to March 4, 2024.
  • The dividend is designated as an eligible dividend for Canadian income tax purposes.

Turning Point Brands Announces Fourth Quarter and Full Year 2023 Results

Retrieved on: 
Wednesday, February 28, 2024
Online Retail, Retail, Convenience Store, Other Retail, Tobacco, Supermarket, Total, CDS, Zigzag, Growth, ID, MST, GAAP, Webcast, EPS, TPB

Stoker’s had an outstanding quarter posting its highest growth rate in over four years led by double-digit growth year-over-year in Stoker’s MST.

Key Points: 
  • Stoker’s had an outstanding quarter posting its highest growth rate in over four years led by double-digit growth year-over-year in Stoker’s MST.
  • For the quarter, the Zig-Zag Products segment gross profit decreased 1.0% to $25.5 million.
  • For the fourth quarter, total Stoker’s Products segment volume increased 14.2%, while price / mix increased 4.4%.
  • For the fourth quarter, CDS net sales were $14.1 million, gross profit was $3.1 million, and gross margin was 22.4%.

Ori Advances Dental Care With Transformative 2.0 Scanner and Tech Membership

Retrieved on: 
Tuesday, February 27, 2024
Health, Dental, Medical Supplies, Medical Devices, DDS, Multimedia, Education, CDS, Patient satisfaction, Dentist, DMD, Dental care, Crown, University, Patient, Dentistry, Faculty, Medical imaging

At the event, Ori, a leading dental technology company at the forefront of innovation, introduced Ori 2.0 and the Ori Tech Membership™ program.

Key Points: 
  • At the event, Ori, a leading dental technology company at the forefront of innovation, introduced Ori 2.0 and the Ori Tech Membership™ program.
  • View the full release here: https://www.businesswire.com/news/home/20240227961176/en/
    A New Accessible Technology Membership: The Ori Tech Membership™ program aims to democratize cutting-edge dental technology through minimal entry costs and affordable monthly payments.
  • Ori PhaseLogic™ Technology: The Ori 2.0 scanner offers unparalleled ease of use and enhances patient care by maximizing the level of detail in impression scanning.
  • Those who invest in Ori Scan 2.0 and the Ori Tech Membership™ are guaranteed the following:
    Ori 2.0 and the Ori Tech Membership™ are expected to revolutionize dental practices with an affordable, efficient, and superior solution to advanced dental care.

Nutrien Increases Quarterly Dividend and Announces Intent to Launch a New Share Repurchase Program

Retrieved on: 
Wednesday, February 21, 2024
Agriculture, Natural Resources, CDS, Bank, TSX, Toronto Stock Exchange, Income Tax Act, Depository Trust Company, Cede and Company, NTR, Security (finance)

This represents an approximately two percent increase from the prior dividend declared on November 1, 2023 and equates to an annualized dividend of US$2.16 per share.

Key Points: 
  • This represents an approximately two percent increase from the prior dividend declared on November 1, 2023 and equates to an annualized dividend of US$2.16 per share.
  • However, registered shareholders of Nutrien may elect to change the currency of their dividend payments to US dollars or Canadian dollars, as applicable.
  • In addition, Nutrien offers registered shareholders direct deposit by electronic funds transfer for dividend payments.
  • All dividends paid by Nutrien are, pursuant to subsection 89(14) of the Income Tax Act (Canada), designated as eligible dividends.